Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01MNK
|
||||
| Former ID |
DIB004042
|
||||
| Drug Name |
BS-194
|
||||
| Synonyms |
BS-194; CDK inhibitors (cancer); CDK inhibitors (cancer), Imperial College London/Emory University
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [542985] | ||
| Company |
Imperial College London
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H27N5O3
|
||||
| InChI |
InChI=1S/C20H27N5O3/c1-13(2)15-10-22-25-19(21-9-14-6-4-3-5-7-14)8-18(24-20(15)25)23-16(11-26)17(28)12-27/h3-8,10,13,16-17,21,26-28H,9,11-12H2,1-2H3,(H,23,24)/t16-,17+/m0/s1
|
||||
| InChIKey |
KRIWIRSMQRQYJG-DLBZAZTESA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Cyclin-dependent kinase | Target Info | Inhibitor | [542984] | |
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.
